Invention Grant
- Patent Title: Transdermal drug administration device
-
Application No.: US13821039Application Date: 2011-09-05
-
Publication No.: US10251834B2Publication Date: 2019-04-09
- Inventor: Håkan Engqvist , Susanne Bredenberg , Anders Pettersson , Thomas Lundqvist , Anna Dahlgren , Anders Sågström
- Applicant: Håkan Engqvist , Susanne Bredenberg , Anders Pettersson , Thomas Lundqvist , Anna Dahlgren , Anders Sågström
- Applicant Address: SE Uppsala
- Assignee: EMPLICURE AB
- Current Assignee: EMPLICURE AB
- Current Assignee Address: SE Uppsala
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/GB2011/051658 WO 20110905
- International Announcement: WO2012/032337 WO 20120315
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/437 ; A61K31/445 ; A61K47/02 ; A61K47/32 ; A61M35/00 ; A61K31/4468 ; A61M37/00

Abstract:
A transdermal drug administration device comprising a drug delivery element (10) defining a contact surface (12) for location, in use, against a patient's skin. The drug delivery element (10) includes a sustained-release pharmaceutical composition. The composition comprises a network of a carrier material having a high mechanical strength and an active pharmaceutical ingredient. The active pharmaceutical ingredient is co-formedly interspersed within pores in the solid, continuous network of the carrier material.
Public/Granted literature
- US20130273119A1 TRANSDERMAL DRUG ADMINISTRATION DEVICE Public/Granted day:2013-10-17
Information query